Recurrent pregnancy loss: An update

Current Opinion in Obstetrics and Gynecology

Volumn 11, Issue 5, 1999, Pages 435-439

  Kutteh, William H ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANDROGEN; CAFFEINE; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY; PLACEBO; PROLACTIN; THYROID ANTIBODY;

ALLOIMMUNITY; AUTOIMMUNE DISEASE; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; EMBRYOTOXICITY; ENVIRONMENTAL FACTOR; FETUS WASTAGE; HUMAN; HYPERANDROGENISM; HYPERPROLACTINEMIA; INDUCED ABORTION; INTRAVENOUS DRUG ADMINISTRATION; NATURAL KILLER CELL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT ABORTION; REVIEW; SOCIAL ASPECT; TOBACCO; TREATMENT OUTCOME;

EID: 0032779111     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199910000-00004     Document Type: Review

References (41)

1. Esplin MS, Branch DW, Silver R, Stagnaro-Green A. Thyroid autoantibodies are not associated with recurrent pregnancy loss. Am J Obstet Gynecol 1998; 179:1583-1586.
2. Wilson R, Ling H, MacLean MA, Mooney J, Kinnane D, McKillop JH, Walker JJ. Thyroid antibody titer and avidity in patients with recurrent miscarriage, Fertil Steril 1999; 71:558-561.
3. Muller AF, Verhoeff A, Mantel MJ, Berghout A. Thyroid autoimmunity and abortion: a prospective study in women undergoing in vitro fertilization, Fertil Steril 1999; 71:30-34. This study demonstrates the lack of association between thyroid peroxidase antibodies and outcome of IVF in women without a history of RPL.
4. Kutteh WH, Yetman DL, Carr AC, Beck LA, Scott RT. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril 1999; 71:843-848. Antithyroid antibodies were not associated with women undergoing IVF but were found more frequently in women with RPL suggesting autoimmune abnormalities.
5. Amengual O, Atsumi T, Khamashta MA, Hughes GRV. Advances in antiphospholipid (Hughes') Syndrome. Ann Acad Med Singapore 1998; 27:61-66.
6. Rand JH. Antiphospholipid antibody syndrome; new insights on thrombogenic mechanisms. Am J Med Sci 1998; 316:142-151. An excellent review that discusses the recent theories on the pathogenic roles of antiphospholipid antibodies.
7. Branch DW. Antiphospholipid antibodies and reproductive outcome: the current state of affairs. J Reprod Immunol 1998; 38:75-87. Summarizes what we know and what we don't know about APA and reproductive outcome. Sets targets for scientific inquiry into this problem.
8. Kutteh WH, Rote NS, Silver R. Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. Am J Reprod Immunol 1999; 41:133-152. An excellent up-to-date review of the history, definitions, assay methodology, pathophysiology, prevalence, clinical manifestations, and management recommendations for women with APA.
9. Simpson JL, Carson SA, Chesney C, Conley MR, Metzger B, Aarons J. et al. Lack of association between antiphospholipid antibodies and first-trimester spontaneous abortion: prospective study of pregnancies detected within 21 days of conception. Fertil Steril 1998; 69:814-820.
10. Di Simone N, Caliandro D, Castellani R, Ferrazzani S, De Carolis S, Caruso A. Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod 1999; 14:489-495.
11. Ober C, Hyslop T, Elias S, Weitkamp LR, Hauck WW. Human leukocyte antigen matching and fetal loss: results of a 10 year prospective study. Hum Reprod 1998; 13:33-38. A conclusive, long-term study that indicates that HLA typing should not be included in the workup of couples with RPL.
12. Chu Wenjiang, Fant ME, Geraghty DE, Hunt JS. Soluble HLA-G in human placentas: synthesis in trophoblasts and interferon-; activated macrophages but not placental fibroblasts. Hum Immun 1998; 59:435-442.
13. Torry DS, Labarrere CA, McIntyre JA. Uteroplacental vascular involvement in recurrent spontaneous abortion. Curr Opin Obstet Gynecol 1998; 10:379-382. Recent advances in pregnancy immunology and vascular biology are reviewed with emphasis upon the events associated with RPL.
14. Kodama TK, Hara T, Okamoto E, Kusunoki Y, Ohama K. Characteristic changes of large granular lymphocytes that strongly express CD56 in endometrium during the menstrual cycle and early pregnancy. Hum Reprod 1998; 13:1035-1043.
15. Vassiliadou N, Bulmer JN. Characterization of endometrial T lymphocyte subpopulations in spontaneous early pregnancy loss. Hum Reprod 1998; 13:44-47.
16. Christian OB, Mathiesen O, Husth M, Rasnussen O, Ingerslev HJ, Lauritsen JG, et al. Placebo-controlled trial of treatment of unexplained recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin. Hum Reprod 1995; 10:2690-2695.
17. The German RSA/IVIG group. Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br J Obstet Gynaecol 1994; 101:1072-1077.
18. Coulam CB, Krysa L, Stern JJ, Bustillo M. Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995; 34:333-337.
19. Perino A, Vassiliadis A, Vvucetich A, Colacurci N, Menato G, Cigniti M, Semprini AE. Short-term therapy for recurrent abortion using intravenous immunoglobulins: results of a double-blind placebo-controlled Italian Study. Hum Reprod 1977; 12:2388-2392.
20. Stephenson MD, Dreher K, Houlihan E, Wu V. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial. Am J Reprod Immunol 1998; 39:82-88. There was no clinically significant difference between the treatment arm and the placebo arm in terms of subsequent pregnancy success in this study of 37 women with RPL.
21. Jablonowska B, Selbing A, Palfi M, Ernerudh J, Kjellberg S, Lindton B. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study. Hum Reprod 1999; 14:838-841. This study of 41 women found no statistically significant difference in treatment results between WIG and placebo in women with RPL.
22. Harris EN, Pierangeli SS. Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: a review. Scand J Rheumatol 1998; 107:97-102. The father of the antiphospholipid syndrome reviews the pros and cons of IVIG and treatment of RPL. The limitations of our current knowledge are outlined.
23. Days S, Gunby J, Clark DA. Intravenous immunoglobulin therapy for recurrent spontaneous abortion: a meta-analysis. Am J Reprod Immunol 1998; 39:69-76. No conclusive evidence is available to demonstrate the efficacy of IVIG in treatment of unexplained RPL.
24. Clark AL, Branch DW, Silver RM, Harris EN, Pierangeli S, Spinnato JA. Pregnancy complicated by the antiphospholipid syndrome: outcomes with intravenous immunoglobulin therapy. Obstet Gynecol 1999; 93:437-441.
25. Ober C, Karrison T, Odem RR, Barnes RB, Branch DW Stephenson MD, et al. Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet 1999; 354:365-369.
26. Quere I, Bellet H, Hoffet M, Janbon C, Mares P, Gris JC. A woman with five consecutive fetal deaths; case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages. Fertil Steril 1998; 68; 152-154.
27. Nelen WLDM, Blom HJ, Thomas CMG, Steegers AP, Boers GHJ, Eskes TKAB, Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr 1998; 128:1336-1341.
28. Kutteh WH, Park VM, Deitcher SR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 1999; 71:1-6. This timely study investigates three coagulation abnormalities that may be associated with RPL.
29. Vincent T, Rai Raj, Regan L, Cohen H. Increased thrombin generation in women with recurrent miscarriage. Lancet 1998; 352:116.
30. Okon MA, Laird SM, Tuckerman EM, Li TC. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of ondometrial function. Fertil Steril 1998; 69:682-690.
31. Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, Minaguchi H. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril 1998; 70:246-252. This randomized trial clearly demonstrates the benefit of normalizing prolactin levels in women with RPL.
32. Dlugi AM. Hyperprolactinemic recurrent spontaneous pregnancy loss: a true clinical entity or a spurious finding? Fertil Steril 1998; 70:253-255.
33. Aoki K, Furukawa T, Ogasawara M, Hori S, Kitamura T. Psychosocial factors in recurrent miscarriages. Acta Obstet Gynecol Scand 1998; 77:572-573.
34. Milad MP, Klock SC, Moses S, Chatterton R. Stress and anxiety do not result in pregnancy wastage. Hum Reprod 1998; 13:2296-2300.
35. Parazzini F, Chatenoud L, Tozzi L, Di Cintio E, Benzi G, Fedele L. Induced abortion in the first trimester of pregnancy and risk of miscarriage. Br J Obstet Gynaecol 1998; 105:418-421.
36. Fenster L,. Ouale C, Hiatt RA, Wilson M, Windham GC, Benowitz NL. Rate of caffeine metabolism and risk of spontaneous abortion. Am J Epidemiol 1998: 147:503-510.
37. Ness RB, Grisso JA, Hirschinger N, Markovic N, Shaw LM, Day NL, Kline J. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med 1999;340:333-339.
38. D'Ubaldo C, Pezzotti P, Rezza G, Branca M, Ippolito G, the DIANAIDS Collaborative Study Group. Association between HIV-1 infection and miscarriage: a retrospective study. AIDS 1998; 12:1087-1093.
39. Sharara FI, Seifer DB, Flaws JA. Environmental toxicants and female reproduction. Fertil Steril 1998; 70:613-622. An excellent overview of environmental factors to avoid to maximize the success of human reproduction.
40. Kutteh WH. Recurrent pregnancy loss. In: Carr BR and Blackwell RE, editors. Textbook of reproductive medicine. 2nd ed. Stamford, Conneticut: Appleton & Lange: 1998, pp. 679-692. A current, rational summary of the current state of diagnosis and treatment of RPL.
41. Li TC. Recurrent miscarriage: principles of management. Hum Reprod 1998; 13:478-482.